Cite
MLA Citation
C.H. Ruhlmann et al.. “34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study.” European journal of cancer, vol. 51, n.d., pp. S727–. http://access.bl.uk/ark:/81055/vdc_100051210954.0x000033